Left Ventricular Geometry and Inferior Vena Cava Diameter Co-Modify the Risk of Cardiovascular Outcomes in Chronic Hemodialysis Patients

被引:0
|
作者
Wu, Chung-Kuan [1 ,2 ]
Wang, Ming [1 ]
Kao, Zih-Kai [3 ]
Yar, Noi [1 ]
Chuang, Ming-Tsang [4 ]
Chang, Tzu-Hao [5 ,6 ]
机构
[1] Shin Kong Wu Ho Su Mem Hosp, Dept Internal Med, Div Nephrol, Taipei 111, Taiwan
[2] Fu Jen Catholic Univ, Sch Med, Taipei 242, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Inst Biophoton, Taipei 112, Taiwan
[4] Taipei Med Univ, Clin Data Ctr, Off Data Sci, Taipei 106339, Taiwan
[5] Taipei Med Univ, Grad Inst Biomed Informat, Taipei 11031, Taiwan
[6] Taipei Med Univ, Clin Big Data Res Ctr, Taipei 11031, Taiwan
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 07期
关键词
concentric left ventricular hypertrophy; eccentric left ventricular hypertrophy; inferior vena cava diameter; major cardiovascular event; mortality; hemodialysis; CONCENTRIC GEOMETRY; VOLUME OVERLOAD; ASSOCIATION; MORBIDITY; MORTALITY; UPDATE;
D O I
10.3390/medicina60071140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Left ventricular hypertrophy (LVH) represents a significant cardiovascular risk in patients undergoing chronic hemodialysis (CHD). A large inferior vena cava diameter (IVCD), potentially indicative of fluid overload and a contributing factor to elevated cardiovascular risk, has not been sufficiently explored. Therefore, our study aims to gain further insights into this aspect. Materials and Methods: A retrospective cohort study enrolled patients receiving CHD in a single medical center with available echocardiography from October to December 2018. They were categorized into four groups based on LVH geometry and IVCD. Cox proportional hazard models assessed the risk of major adverse cardiovascular effects (MACEs) and cardiovascular and overall mortality after multivariate adjustments. Kaplan-Meier analysis depicted MACE-free events and survival during the follow-up time. Results: Of the 175 CHD patients, 38, 42, 45, and 50 exhibited small IVCD with eccentric and concentric LVH and large IVCD with eccentric and concentric LVH, respectively. Compared to small IVCD and eccentric LVH, large IVCD and eccentric LVH had the highest risk of MACEs, followed by large IVCD and concentric LVH (aHR: 4.40, 3.60; 95% CI: 1.58-12.23, 1.28-10.12, respectively). As for cardiovascular mortality, large IVCD and concentric LVH had the highest risk, followed by large IVCD and eccentric LVH, and small IVCD and concentric LVH. (aHR: 14.34, 10.23, 8.87; 95% CI: 1.99-103.35, 1.41-74.33; 1.01-77.87). The trend in overall mortality risk among the groups was similar to that of cardiovascular mortality. Conclusions: LVH geometry and IVCD co-modify the risk of MACEs and cardiovascular and overall mortality in CHD patients. The highest risk of MACEs is associated with large IVCD and eccentric LVH, while the highest risk of cardiovascular and overall mortality is linked with large IVCD and concentric LVH.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Risk factors for left ventricular hypertrophy in chronic hemodialysis patients
    Washio, M
    Okuda, S
    Mizoue, T
    Kiyama, S
    Ando, T
    Sanai, T
    Hirakata, H
    Nanishi, F
    Kiyohara, C
    Ogimoto, I
    Yoshimura, T
    Fujishima, M
    CLINICAL NEPHROLOGY, 1997, 47 (06) : 362 - 366
  • [22] Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity
    Antonio Iaconelli
    Joe Cuthbert
    Syed Kazmi
    Pasquale Maffia
    Andrew L. Clark
    John G. F. Cleland
    Pierpaolo Pellicori
    Clinical Research in Cardiology, 2023, 112 : 1077 - 1086
  • [23] Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity
    Iaconelli, Antonio
    Cuthbert, Joe
    Kazmi, Syed
    Maffia, Pasquale
    Clark, Andrew L.
    Cleland, John G. F.
    Pellicori, Pierpaolo
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (08) : 1077 - 1086
  • [24] Left ventricular diastolic dysfunction predicts increased risk of cardiovascular events in patients on chronic hemodialysis with preserved left ventricular systolic function
    Takase, H.
    Okado, T.
    Toriyama, T.
    Tanaka, S.
    Suzuki, F.
    Terada, T.
    Kaneko, M.
    Kimura, G.
    Dohi, Y.
    EUROPEAN HEART JOURNAL, 2007, 28 : 178 - 178
  • [25] Inferior vena cava collapsibility index, renal dysfunction, and adverse outcomes in patients with broad spectrum cardiovascular disease
    Kim, Yong-Hyun
    Kim, Sunwon
    Kim, Jin-Seok
    Lim, Sang-Yup
    Shim, Wan-Joo
    Ahn, Jeong-Cheon
    Song, Woo-Hyuk
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2017, 34 (01): : 20 - 28
  • [26] Elderly patients in chronic hemodialysis: Risk factors for left ventricular hypertrophy
    Neves, PL
    Silva, AP
    Bernardo, I
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (02) : 224 - 228
  • [27] Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants
    Zhao, Xinju
    Zhu, Li
    Jin, Wenying
    Yang, Bing
    Wang, Yan
    Ni, Mengfan
    Zhao, Yuchao
    Gan, Liangying
    Zuo, Li
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [28] Usefulness of Serial Measurements of Inferior Vena Cava Diameter by Vscan™ to Identify Patients With Heart Failure at High Risk of Hospitalization
    Khandwalla, Raj M.
    Birkeland, Kade T.
    Zimmer, Raymond
    Henry, Timothy D.
    Nazarian, Roland
    Sudan, Madhuri
    Mirocha, James
    Cha, Jeena
    Kedan, Ilan
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (10): : 1631 - 1636
  • [29] Relationship of galectin-3 to left ventricular geometry and hypertrophy in chronic hemodialysis patients
    Yilmaz, H.
    Gurel, O. M.
    Celik, H. T.
    Bozkurt, A.
    Yildirim, M. E.
    Bilgic, I.
    Bilgic, M. A.
    Bavbek, N.
    Akcay, A.
    HERZ, 2015, 40 (04) : 702 - 708
  • [30] Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants
    Xinju Zhao
    Li Zhu
    Wenying Jin
    Bing Yang
    Yan Wang
    Mengfan Ni
    Yuchao Zhao
    Liangying Gan
    Li Zuo
    BMC Cardiovascular Disorders, 22